Meaningful translational research to move from preclinical insights to patient impact

 

Friday, 21 May 2027

Course directors:

  • Franziska Eckert 

  • Pierre Montay-Gruel 

Course aim: 

This course aims to critically examine why promising radiobiological findings often fail to translate into clinical benefit and to provide participants with practical strategies to improve the relevance and robustness of preclinical research in radiation oncology. By identifying key gaps between experimental design and clinical reality, and by integrating emerging dimensions such as dose rate, fractionation, spatial dose distribution, and radiation quality, the course will equip attendees with a structured framework to design more predictive, translationally meaningful studies that can more reliably bridge the gap between laboratory discovery and patient care.

Attendees should be able to assess translational ideas for their practicability and chance of success, They should be able to name standard questions before starting translational programs.

Learning objectives: 

This course aims to critically examine why promising radiobiological findings often fail to translate into clinical benefit and to provide participants with practical strategies to improve the relevance and robustness of preclinical research in radiation oncology. By identifying key gaps between experimental design and clinical reality, and by integrating emerging dimensions such as dose rate, fractionation, spatial dose distribution, and radiation quality, the course will equip attendees with a structured framework to design more predictive, translationally meaningful studies that can more reliably bridge the gap between laboratory discovery and patient care.

Target audience

Clinicians, Physicists, Biologists, RTTs and all radiation oncology professionals interested and/or involved in translational research or clinical trials involving translational programs

Scientific programme

The scientific programme is available here.

Pre-course Webinar

More information to be published soon.

Accreditation

Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.